Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Maria Grazia Spillantini

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Disorders

Anatomy

Concepts & Ideas

Phenomena

Phosphorylation

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Pereira J M S; Williams G B; Acosta-Cabronero J; Pengas G; Spillantini M G; Xuereb J H; Hodges J R; Nestor P J
Atrophy patterns in histologic vs clinical groupings of frontotemporal lobar degeneration.
Anderson Jane Marian; Patani Rickie; Reynolds Richard; Nicholas Richard; Compston Alastair; Spillantini Maria Grazia; Chandran Siddharthan
Evidence for abnormal tau phosphorylation in early aggressive multiple sclerosis.
Bridge Katherine E; Berg Nicola; Adalbert Robert; Babetto Elisabetta; Dias Tatyana; Spillantini Maria-Grazia; Ribchester Richard R; Coleman Michael P
Late onset distal axonal swelling in YFP-H transgenic mice.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Maria Grazia Spillantini (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Pereira J M S; Williams G B; Acosta-Cabronero J; Pengas G; Spillantini M G; Xuereb J H; Hodges J R; Nestor P J
Atrophy patterns in histologic vs clinical groupings of frontotemporal lobar degeneration.
Neurology 2009;72(19):1653-60.
2009: Anderson Jane Marian; Patani Rickie; Reynolds Richard; Nicholas Richard; Compston Alastair; Spillantini Maria Grazia; Chandran Siddharthan
Evidence for abnormal tau phosphorylation in early aggressive multiple sclerosis.
Acta neuropathologica 2009;117(5):583-9.
2009: Bridge Katherine E; Berg Nicola; Adalbert Robert; Babetto Elisabetta; Dias Tatyana; Spillantini Maria-Grazia; Ribchester Richard R; Coleman Michael P
Late onset distal axonal swelling in YFP-H transgenic mice.
Neurobiology of aging 2009;30(2):309-21.
2009: Borroni B; Gardoni F; Parnetti L; Magno L; Malinverno M; Saggese E; Calabresi P; Spillantini M G; Padovani A; Di Luca M
Pattern of Tau forms in CSF is altered in progressive supranuclear palsy.
Neurobiology of aging 2009;30(1):34-40.
2008: Costa Cinzia; Belcastro Vincenzo; Tozzi Alessandro; Di Filippo Massimiliano; Tantucci Michela; Siliquini Sabrina; Autuori Alessia; Picconi Barbara; Spillantini Maria Grazia; Fedele Ernesto; Pittaluga Anna; Raiteri Maurizio; Calabresi Paolo
Electrophysiology and pharmacology of striatal neuronal dysfunction induced by mitochondrial complex I inhibition.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2008;28(32):8040-52.
2008: Anderson J M; Hampton D W; Patani R; Pryce G; Crowther R A; Reynolds R; Franklin R J M; Giovannoni G; Compston D A S; Baker D; Spillantini M G; Chandran S
Abnormally phosphorylated tau is associated with neuronal and axonal loss in experimental autoimmune encephalomyelitis and multiple sclerosis.
Brain : a journal of neurology 2008;131(Pt 7):1736-48.
2008: Ye Liang; Velasco Ana; Fraser Graham; Beach Thomas G; Sue Lucia; Osredkar Tracy; Libri Vincenzo; Spillantini Maria Grazia; Goedert Michel; Lockhart Andrew
In vitro high affinity alpha-synuclein binding sites for the amyloid imaging agent PIB are not matched by binding to Lewy bodies in postmortem human brain.
Journal of neurochemistry 2008;105(4):1428-37.
2008: Delobel Patrice; Lavenir Isabelle; Fraser Graham; Ingram Esther; Holzer Max; Ghetti Bernardino; Spillantini Maria Grazia; Crowther R Anthony; Goedert Michel
Analysis of tau phosphorylation and truncation in a mouse model of human tauopathy.
The American journal of pathology 2008;172(1):123-31.
2008: Spina Salvatore; Farlow Martin R; Unverzagt Frederick W; Kareken David A; Murrell Jill R; Fraser Graham; Epperson Francine; Crowther R Anthony; Spillantini Maria G; Goedert Michel; Ghetti Bernardino
The tauopathy associated with mutation +3 in intron 10 of Tau: characterization of the MSTD family.
Brain : a journal of neurology 2008;131(Pt 1):72-89.
2007: Magnani Enrico; Fan Juan; Gasparini Laura; Golding Matthew; Williams Meredith; Schiavo Giampietro; Goedert Michel; Amos Linda A; Spillantini Maria Grazia
Interaction of tau protein with the dynactin complex.
The EMBO journal 2007;26(21):4546-54.
2007: Tofaris G K; Spillantini M G
Physiological and pathological properties of alpha-synuclein.
Cellular and molecular life sciences : CMLS 2007;64(17):2194-201.
2007: Goris An; Williams-Gray Caroline H; Clark Graeme R; Foltynie Thomas; Lewis Simon J G; Brown Joanne; Ban Maria; Spillantini Maria G; Compston Alastair; Burn David J; Chinnery Patrick F; Barker Roger A; Sawcer Stephen J
Tau and alpha-synuclein in susceptibility to, and dementia in, Parkinson's disease.
Annals of neurology 2007;62(2):145-53.
2007: Lambourne Sarah L; Humby Trevor; Isles Anthony R; Emson Piers C; Spillantini Maria G; Wilkinson Lawrence S
Impairments in impulse control in mice transgenic for the human FTDP-17 tauV337M mutation are exacerbated by age.
Human molecular genetics 2007;16(14):1708-19.
2007: van Swieten John; Spillantini Maria Grazia
Hereditary frontotemporal dementia caused by Tau gene mutations.
Brain pathology (Zurich, Switzerland) 2007;17(1):63-73.
2007: Michell A W; Tofaris G K; Gossage H; Tyers P; Spillantini M G; Barker R A
The effect of truncated human alpha-synuclein (1-120) on dopaminergic cells in a transgenic mouse model of Parkinson's disease.
Cell transplantation 2007;16(5):461-74.
2007: Gasparini Laura; Terni Beatrice; Spillantini Maria Grazia
Frontotemporal dementia with tau pathology.
Neuro-degenerative diseases 2007;4(2-3):236-53.
2006: Goedert Michel; Spillantini Maria Grazia
A century of Alzheimer's disease.
Science (New York, N.Y.) 2006;314(5800):777-81.
2006: Goedert Michel; Spillantini Maria Grazia
Frontotemporal lobar degeneration through loss of progranulin function.
Brain : a journal of neurology 2006;129(Pt 11):2808-10.
2006: Tofaris George K; Garcia Reitböck Pablo; Humby Trevor; Lambourne Sarah L; O'Connell Mark; Ghetti Bernardino; Gossage Helen; Emson Piers C; Wilkinson Lawrence S; Goedert Michel; Spillantini Maria Grazia
Pathological changes in dopaminergic nerve cells of the substantia nigra and olfactory bulb in mice transgenic for truncated human alpha-synuclein(1-120): implications for Lewy body disorders.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2006;26(15):3942-50.
2006: Majed Henry H; Chandran Siddharthan; Niclou Simone P; Nicholas Richard S; Wilkins Alastair; Wing Mark G; Rhodes Kate E; Spillantini Maria Grazia; Compston Alastair
A novel role for Sema3A in neuroprotection from injury mediated by activated microglia.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2006;26(6):1730-8.
2006: Bak Thomas H; Yancopoulou Despina; Nestor Peter J; Xuereb John H; Spillantini Maria G; Pulvermüller Friedemann; Hodges John R
Clinical, imaging and pathological correlates of a hereditary deficit in verb and action processing.
Brain : a journal of neurology 2006;129(Pt 2):321-32.
2006: Spillantini Maria Grazia; Murrell Jill R; Goedert Michel; Farlow Martin; Klug Aaron; Ghetti Bernardino
Mutations in the tau gene (MAPT) in FTDP-17: the family with Multiple System Tauopathy with Presenile Dementia (MSTD).
Journal of Alzheimer's disease : JAD 2006;9(3 Suppl):373-80.
2005: Borroni Barbara; Yancopoulou Despina; Tsutsui Miho; Padovani Alessandro; Sawcer Stephen J; Hodges John R; Spillantini Maria Grazia
Association between tau H2 haplotype and age at onset in frontotemporal dementia.
Archives of neurology 2005;62(9):1419-22.
2005: Tofaris George K; Spillantini Maria Grazia
Alpha-synuclein dysfunction in Lewy body diseases.
Movement disorders : official journal of the Movement Disorder Society 2005;20 Suppl 12():S37-44.
2005: Skibinski Gaia; Parkinson Nicholas J; Brown Jeremy M; Chakrabarti Lisa; Lloyd Sarah L; Hummerich Holger; Nielsen Jørgen E; Hodges John R; Spillantini Maria Grazia; Thusgaard Tove; Brandner Sebastian; Brun Arne; Rossor Martin N; Gade Anders; Johannsen Peter; Sørensen Sven Asger; Gydesen Susanne; Fisher Elizabeth M C; Collinge John
Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia.
Nature genetics 2005;37(8):806-8.
2005: Yancopoulou Despina; Xuereb John H; Crowther R Anthony; Hodges John R; Spillantini Maria Grazia
Tau and alpha-synuclein inclusions in a case of familial frontotemporal dementia and progressive aphasia.
Journal of neuropathology and experimental neurology 2005;64(3):245-53.
2005: Calò Laura; Spillantini Mariagrazia; Nicoletti F; Allen Nicholas D
Nurr1 co-localizes with EphB1 receptors in the developing ventral midbrain, and its expression is enhanced by the EphB1 ligand, ephrinB2.
Journal of neurochemistry 2005;92(2):235-45.
2004: Bruni A C; Kawarai T; Spillantini M G; St-George Hyslop P H; Leotta A; Lio S; Foncin J-F; El Hachimi K H
[Familial fronto-temporal dementia with brain stem ubiquitin-positive neuronal inclusions]
Revue neurologique 2004;160(12):1171-9.
2004: Piguet O; Brooks W S; Halliday G M; Schofield P R; Stanford P M; Kwok J B J; Spillantini M-G; Yancopoulou D; Nestor P J; Broe G A; Hodges J R
Similar early clinical presentations in familial and non-familial frontotemporal dementia.
Journal of neurology, neurosurgery, and psychiatry 2004;75(12):1743-5.
2004: Bellucci Arianna; Westwood Andrew J; Ingram Esther; Casamenti Fiorella; Goedert Michel; Spillantini Maria Grazia
Induction of inflammatory mediators and microglial activation in mice transgenic for mutant human P301S tau protein.
The American journal of pathology 2004;165(5):1643-52.
2004: Takao Masaki; Ghetti Bernardino; Yoshida Hirotaka; Piccardo Pedro; Narain Yolanda; Murrell Jill R; Vidal Ruben; Glazier Bradley S; Jakes Ross; Tsutsui Miho; Spillantini Maria Grazia; Crowther R Anthony; Goedert Michel; Koto Atsuo
Early-onset dementia with Lewy bodies.
Brain pathology (Zurich, Switzerland) 2004;14(2):137-47.
2004: Brown Jerry; Gydesen Susanne; Johannsen Peter; Gade Anders; Skibinski Gaia; Chakrabarti Lisa; Brun Arne; Spillantini Maria; Yancopoulou Despina; Thusgaard Tove; Sorensen Asger; Fisher Elizabeth; Collinge John;
Frontotemporal dementia linked to chromosome 3.
Dementia and geriatric cognitive disorders 2004;17(4):274-6.
2003: Tofaris George K; Razzaq Azam; Ghetti Bernardino; Lilley Kathryn S; Spillantini Maria Grazia
Ubiquitination of alpha-synuclein in Lewy bodies is a pathological event not associated with impairment of proteasome function.
The Journal of biological chemistry 2003;278(45):44405-11.
2003: Yancopoulou Despina; Crowther R Anthony; Chakrabarti Lisa; Gydesen Susanne; Brown Jeremy M; Spillantini Maria Grazia
Tau protein in frontotemporal dementia linked to chromosome 3 (FTD-3).
Journal of neuropathology and experimental neurology 2003;62(8):878-82.
2003: Powers J M; Byrne N P; Ito M; Takao M; Yankopoulou D; Spillantini M G; Ghetti B
A novel leukoencephalopathy associated with tau deposits primarily in white matter glia.
Acta neuropathologica 2003;106(2):181-7.
2003: Yancopoulou Despina; Spillantini Maria Grazia
Tau protein in familial and sporadic diseases.
Neuromolecular medicine 2003;4(1-2):37-48.
2002: Ingram Esther M; Spillantini Maria G
Tau gene mutations: dissecting the pathogenesis of FTDP-17.
Trends in molecular medicine 2002;8(12):555-62.
2002: Gydesen S; Brown J M; Brun A; Chakrabarti L; Gade A; Johannsen P; Rossor M; Thusgaard T; Grove A; Yancopoulou D; Spillantini M G; Fisher E M C; Collinge J; Sorensen S A
Chromosome 3 linked frontotemporal dementia (FTD-3).
Neurology 2002;59(10):1585-94.
2002: Allen Bridget; Ingram Esther; Takao Masaki; Smith Michael J; Jakes Ross; Virdee Kanwar; Yoshida Hirotaka; Holzer Max; Craxton Molly; Emson Piers C; Atzori Cristiana; Migheli Antonio; Crowther R Anthony; Ghetti Bernardino; Spillantini Maria Grazia; Goedert Michel
Abundant tau filaments and nonapoptotic neurodegeneration in transgenic mice expressing human P301S tau protein.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2002;22(21):9340-51.
2002: David Della C; Layfield Robert; Serpell Louise; Narain Yolanda; Goedert Michel; Spillantini Maria Grazia
Proteasomal degradation of tau protein.
Journal of neurochemistry 2002;83(1):176-85.
2001: Tofaris G K; Layfield R; Spillantini M G
alpha-synuclein metabolism and aggregation is linked to ubiquitin-independent degradation by the proteasome.
FEBS letters 2001;509(1):22-6.
2001: Spillantini M G; Goedert M
Tau and Parkinson disease.
JAMA : the journal of the American Medical Association 2001;286(18):2324-6.
2001: Neumann M; Schulz-Schaeffer W; Crowther R A; Smith M J; Spillantini M G; Goedert M; Kretzschmar H A
Pick's disease associated with the novel Tau gene mutation K369I.
Annals of neurology 2001;50(4):503-13.
2001: Rosso S M; Kamphorst W; de Graaf B; Willemsen R; Ravid R; Niermeijer M F; Spillantini M G; Heutink P; van Swieten J C
Familial frontotemporal dementia with ubiquitin-positive inclusions is linked to chromosome 17q21-22.
Brain : a journal of neurology 2001;124(Pt 10):1948-57.
2001: Goedert M; Spillantini M G; Serpell L C; Berriman J; Smith M J; Jakes R; Crowther R A
From genetics to pathology: tau and alpha-synuclein assemblies in neurodegenerative diseases.
Philosophical transactions of the Royal Society of London. Series B, Biological sciences 2001;356(1406):213-27.
2001: Goedert M; Spillantini M G
Tau gene mutations and neurodegeneration.
Biochemical Society symposium 2001;(67):59-71.
2001: Spillantini M G; Goedert M
Tau gene mutations and tau pathology in frontotemporal dementia and parkinsonism linked to chromosome 17.
Advances in experimental medicine and biology 2001;487():21-37.
2000: Spillantini M G; Yoshida H; Rizzini C; Lantos P L; Khan N; Rossor M N; Goedert M; Brown J
A novel tau mutation (N296N) in familial dementia with swollen achromatic neurons and corticobasal inclusion bodies.
Annals of neurology 2000;48(6):939-43.
2000: Rizzini C; Goedert M; Hodges J R; Smith M J; Jakes R; Hills R; Xuereb J H; Crowther R A; Spillantini M G
Tau gene mutation K257T causes a tauopathy similar to Pick's disease.
Journal of neuropathology and experimental neurology 2000;59(11):990-1001.
2000: Goedert M; Spillantini M G
Tau mutations in frontotemporal dementia FTDP-17 and their relevance for Alzheimer's disease.
Biochimica et biophysica acta 2000;1502(1):110-21.
2000: Probst A; Götz J; Wiederhold K H; Tolnay M; Mistl C; Jaton A L; Hong M; Ishihara T; Lee V M; Trojanowski J Q; Jakes R; Crowther R A; Spillantini M G; Bürki K; Goedert M
Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein.
Acta neuropathologica 2000;99(5):469-81.
2000: Spillantini M G; Goedert M
Tau mutations in familial frontotemporal dementia.
Brain : a journal of neurology 2000;123 ( Pt 5)():857-9.
2000: Yasuda M; Takamatsu J; D'Souza I; Crowther R A; Kawamata T; Hasegawa M; Hasegawa H; Spillantini M G; Tanimukai S; Poorkaj P; Varani L; Varani G; Iwatsubo T; Goedert M; Schellenberg D G; Tanaka C
A novel mutation at position +12 in the intron following exon 10 of the tau gene in familial frontotemporal dementia (FTD-Kumamoto)
Annals of neurology 2000;47(4):422-9.
2000: Spillantini M G; Van Swieten J C; Goedert M
Tau gene mutations in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17).
Neurogenetics 2000;2(4):193-205.
2000: Varani L; Spillantini M G; Goedert M; Varani G
Structural basis for recognition of the RNA major groove in the tau exon 10 splicing regulatory element by aminoglycoside antibiotics.
Nucleic acids research 2000;28(3):710-9.
2000: Goedert M; Ghetti B; Spillantini M G
Tau gene mutations in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17). Their relevance for understanding the neurogenerative process.
Annals of the New York Academy of Sciences 2000;920():74-83.
2000: Ghetti B; Murrell J R; Zolo P; Spillantini M G; Goedert M
Progress in hereditary tauopathies: a mutation in the Tau gene (G389R) causes a Pick disease-like syndrome.
Annals of the New York Academy of Sciences 2000;920():52-62.
2000: Spillantini M G; Goedert M
The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy.
Annals of the New York Academy of Sciences 2000;920():16-27.
1999: Spillantini M G
Parkinson's disease, dementia with Lewy bodies and multiple system atrophy are alpha-synucleinopathies.
Parkinsonism & related disorders 1999;5(4):157-62.
1999: Murrell J R; Spillantini M G; Zolo P; Guazzelli M; Smith M J; Hasegawa M; Redi F; Crowther R A; Pietrini P; Ghetti B; Goedert M
Tau gene mutation G389R causes a tauopathy with abundant pick body-like inclusions and axonal deposits.
Journal of neuropathology and experimental neurology 1999;58(12):1207-26.
1999: Ghetti B; Murrell J; Spillantini M G
Mutations in the Tau gene cause frontotemporal dementia.
Brain research bulletin 1999;50(5-6):471-2.
1999: van Swieten J C; Stevens M; Rosso S M; Rizzu P; Joosse M; de Koning I; Kamphorst W; Ravid R; Spillantini M G; Niermeijer; Heutink P
Phenotypic variation in hereditary frontotemporal dementia with tau mutations.
Annals of neurology 1999;46(4):617-26.
1999: Hulette C M; Pericak-Vance M A; Roses A D; Schmechel D E; Yamaoka L H; Gaskell P C; Welsh-Bohmer K A; Crowther R A; Spillantini M G
Neuropathological features of frontotemporal dementia and parkinsonism linked to chromosome 17q21-22 (FTDP-17): Duke Family 1684.
Journal of neuropathology and experimental neurology 1999;58(8):859-66.
1999: Varani L; Hasegawa M; Spillantini M G; Smith M J; Murrell J R; Ghetti B; Klug A; Goedert M; Varani G
Structure of tau exon 10 splicing regulatory element RNA and destabilization by mutations of frontotemporal dementia and parkinsonism linked to chromosome 17.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(14):8229-34.
1999: Spillantini M G; Tolnay M; Love S; Goedert M
Microtubule-associated protein tau, heparan sulphate and alpha-synuclein in several neurodegenerative diseases with dementia.
Acta neuropathologica 1999;97(6):585-94.
1999: Bugiani O; Murrell J R; Giaccone G; Hasegawa M; Ghigo G; Tabaton M; Morbin M; Primavera A; Carella F; Solaro C; Grisoli M; Savoiardo M; Spillantini M G; Tagliavini F; Goedert M; Ghetti B
Frontotemporal dementia and corticobasal degeneration in a family with a P301S mutation in tau.
Journal of neuropathology and experimental neurology 1999;58(6):667-77.
1999: Mirra S S; Murrell J R; Gearing M; Spillantini M G; Goedert M; Crowther R A; Levey A I; Jones R; Green J; Shoffner J M; Wainer B H; Schmidt M L; Trojanowski J Q; Ghetti B
Tau pathology in a family with dementia and a P301L mutation in tau.
Journal of neuropathology and experimental neurology 1999;58(4):335-45.
1999: Hasegawa M; Cuenda A; Spillantini M G; Thomas G M; Buée-Scherrer V; Cohen P; Goedert M
Stress-activated protein kinase-3 interacts with the PDZ domain of alpha1-syntrophin. A mechanism for specific substrate recognition.
The Journal of biological chemistry 1999;274(18):12626-31.
1999: Goedert M; Spillantini M G; Crowther R A; Chen S G; Parchi P; Tabaton M; Lanska D J; Markesbery W R; Wilhelmsen K C; Dickson D W; Petersen R B; Gambetti P
Tau gene mutation in familial progressive subcortical gliosis.
Nature medicine 1999;5(4):454-7.
1999: Kimonides V G; Spillantini M G; Sofroniew M V; Fawcett J W; Herbert J
Dehydroepiandrosterone antagonizes the neurotoxic effects of corticosterone and translocation of stress-activated protein kinase 3 in hippocampal primary cultures.
Neuroscience 1999;89(2):429-36.
1998: Goedert M; Spillantini M G
Lewy body diseases and multiple system atrophy as alpha-synucleinopathies.
Molecular psychiatry 1998;3(6):462-5.
1998: Goedert M; Crowther R A; Spillantini M G
Tau mutations cause frontotemporal dementias.
Neuron 1998;21(5):955-8.
1998: Spillantini M G; Crowther R A; Kamphorst W; Heutink P; van Swieten J C
Tau pathology in two Dutch families with mutations in the microtubule-binding region of tau.
The American journal of pathology 1998;153(5):1359-63.
1998: Goedert M; Spillantini M G; Davies S W
Filamentous nerve cell inclusions in neurodegenerative diseases.
Current opinion in neurobiology 1998;8(5):619-32.
1998: Crowther R A; Jakes R; Spillantini M G; Goedert M
Synthetic filaments assembled from C-terminally truncated alpha-synuclein.
FEBS letters 1998;436(3):309-12.
1998: Spillantini M G; Goedert M
Tau protein pathology in neurodegenerative diseases.
Trends in neurosciences 1998;21(10):428-33.
1998: Goedert M; Jakes R; Crowther R A; Hasegawa M; Smith M J; Spillantini M G
Intraneuronal filamentous tau protein and alpha-synuclein deposits in neurodegenerative diseases.
Biochemical Society transactions 1998;26(3):463-71.
1998: Spillantini M G; Crowther R A; Jakes R; Cairns N J; Lantos P L; Goedert M
Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies.
Neuroscience letters 1998;251(3):205-8.
1998: Spillantini M G; Murrell J R; Goedert M; Farlow M R; Klug A; Ghetti B
Mutation in the tau gene in familial multiple system tauopathy with presenile dementia.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(13):7737-41.
1998: Spillantini M G; Crowther R A; Jakes R; Hasegawa M; Goedert M
alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(11):6469-73.
1998: Spillantini M G; Bird T D; Ghetti B
Frontotemporal dementia and Parkinsonism linked to chromosome 17: a new group of tauopathies.
Brain pathology (Zurich, Switzerland) 1998;8(2):387-402.
1998: Lowe J; Spillantini M G
Non-Alzheimer degenerative dementias.
Brain pathology (Zurich, Switzerland) 1998;8(2):295-7.
1997: Murrell J R; Koller D; Foroud T; Goedert M; Spillantini M G; Edenberg H J; Farlow M R; Ghetti B
Familial multiple-system tauopathy with presenile dementia is localized to chromosome 17.
American journal of human genetics 1997;61(5):1131-8.
1997: Spillantini M G; Schmidt M L; Lee V M; Trojanowski J Q; Jakes R; Goedert M
Alpha-synuclein in Lewy bodies.
Nature 1997;388(6645):839-40.
1997: Chevallier N; Jiracek J; Vincent B; Baur C P; Spillantini M G; Goedert M; Dive V; Checler F
Examination of the role of endopeptidase 3.4.24.15 in A beta secretion by human transfected cells.
British journal of pharmacology 1997;121(3):556-62.
1997: Tolnay M; Spillantini M G; Goedert M; Ulrich J; Langui D; Probst A
Argyrophilic grain disease: widespread hyperphosphorylation of tau protein in limbic neurons.
Acta neuropathologica 1997;93(5):477-84.
1997: Spillantini M G; Goedert M; Crowther R A; Murrell J R; Farlow M R; Ghetti B
Familial multiple system tauopathy with presenile dementia: a disease with abundant neuronal and glial tau filaments.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(8):4113-8.
1997: Chevallier N; Vizzavona J; Marambaud P; Baur C P; Spillantini M; Fulcrand P; Martinez J; Goedert M; Vincent J P; Checler F
Cathepsin D displays in vitro beta-secretase-like specificity.
Brain research 1997;750(1-2):11-9.
1996: Probst A; Tolnay M; Langui D; Goedert M; Spillantini M G
Pick's disease: hyperphosphorylated tau protein segregates to the somatoaxonal compartment.
Acta neuropathologica 1996;92(6):588-96.
1996: Goedert M; Baur C P; Ahringer J; Jakes R; Hasegawa M; Spillantini M G; Smith M J; Hill F
PTL-1, a microtubule-associated protein with tau-like repeats from the nematode Caenorhabditis elegans.
Journal of cell science 1996;109 ( Pt 11)():2661-72.
1996: Goedert M; Jakes R; Spillantini M G; Hasegawa M; Smith M J; Crowther R A
Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans.
Nature 1996;383(6600):550-3.
1996: Spillantini M G; Crowther R A; Goedert M
Comparison of the neurofibrillary pathology in Alzheimer's disease and familial presenile dementia with tangles.
Acta neuropathologica 1996;92(1):42-8.
1996: Ghetti B; Piccardo P; Spillantini M G; Ichimiya Y; Porro M; Perini F; Kitamoto T; Tateishi J; Seiler C; Frangione B; Bugiani O; Giaccone G; Prelli F; Goedert M; Dlouhy S R; Tagliavini F
Vascular variant of prion protein cerebral amyloidosis with tau-positive neurofibrillary tangles: the phenotype of the stop codon 145 mutation in PRNP.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(2):744-8.
1996: Goedert M; Spillantini M G; Hasegawa M; Jakes R; Crowther R A; Klug A
Molecular dissection of the neurofibrillary lesions of Alzheimer's disease.
Cold Spring Harbor symposia on quantitative biology 1996;61():565-73.
1995: Goedert M; Spillantini M G; Jakes R; Crowther R A; Vanmechelen E; Probst A; Götz J; Bürki K; Cohen P
Molecular dissection of the paired helical filament.
Neurobiology of aging 1995;16(3):325-34.
1995: Spillantini M G; Divane A; Goedert M
Assignment of human alpha-synuclein (SNCA) and beta-synuclein (SNCB) genes to chromosomes 4q21 and 5q35.
Genomics 1995;27(2):379-81.
1995: Götz J; Probst A; Spillantini M G; Schäfer T; Jakes R; Bürki K; Goedert M
Somatodendritic localization and hyperphosphorylation of tau protein in transgenic mice expressing the longest human brain tau isoform.
The EMBO journal 1995;14(7):1304-13.
1995: Goedert M; Jakes R; Spillantini M G; Crowther R A; Cohen P; Vanmechelen E; Probst A; Götz J; Bürki K
Tau protein in Alzheimer's disease.
Biochemical Society transactions 1995;23(1):80-5.
1995: Jakes R; Harrington C R; Spillantini M G; Goedert M; Klug A
Characterisation of an antibody relevant to the neuropathology of Alzheimer disease.
Alzheimer disease and associated disorders 1995;9(1):47-51.
1994: Jakes R; Spillantini M G; Goedert M
Identification of two distinct synucleins from human brain.
FEBS letters 1994;345(1):27-32.
1993: Matucci-Cerinic M; Lombardi A; Leoncini G; Pignone A; Sacerdoti L; Spillantini M G; Partsch G
Neutral endopeptidase (3.4.24.11) in plasma and synovial fluid of patients with rheumatoid arthritis. A marker of disease activity or a regulator of pain and inflammation?
Rheumatology international 1993;13(1):1-4.
1993: Aloe L; Probert L; Kollias G; Bracci-Laudiero L; Spillantini M G; Levi-Montalcini R
The synovium of transgenic arthritic mice expressing human tumor necrosis factor contains a high level of nerve growth factor.
Growth factors (Chur, Switzerland) 1993;9(2):149-55.
1992: Goedert M; Spillantini M G; Crowther R A
Cloning of a big tau microtubule-associated protein characteristic of the peripheral nervous system.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(5):1983-7.
1992: Goedert M; Spillantini M G; Cairns N J; Crowther R A
Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms.
Neuron 1992;8(1):159-68.
1992: Potier M C; Spillantini M G; Carter N P
The human glutamate receptor cDNA GluR1: cloning, sequencing, expression and localization to chromosome 5.
DNA sequence : the journal of DNA sequencing and mapping 1992;2(4):211-8.
1991: Goedert M; Spillantini M G; Crowther R A
Tau proteins and neurofibrillary degeneration.
Brain pathology (Zurich, Switzerland) 1991;1(4):279-86.
1991: Boehm T; Spillantini M G; Sofroniew M V; Surani M A; Rabbitts T H
Developmentally regulated and tissue specific expression of mRNAs encoding the two alternative forms of the LIM domain oncogene rhombotin: evidence for thymus expression.
Oncogene 1991;6(5):695-703.
1991: Goedert M; Spillantini M G; Jakes R
Localization of the Alz-50 epitope in recombinant human microtubule-associated protein tau.
Neuroscience letters 1991;126(2):149-54.
1990: Oliveira E S; Leite P E; Spillantini M G; Camargo A C; Hunt S P
Localization of endo-oligopeptidase (EC 3.4.22.19) in the rat nervous tissue.
Journal of neurochemistry 1990;55(4):1114-21.
1990: Spillantini M G; Goedert M; Jakes R; Klug A
Different configurational states of beta-amyloid and their distributions relative to plaques and tangles in Alzheimer disease.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(10):3947-51.
1990: Spillantini M G; Goedert M; Jakes R; Klug A
Topographical relationship between beta-amyloid and tau protein epitopes in tangle-bearing cells in Alzheimer disease.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(10):3952-6.
1990: Spillantini M G; Sicuteri F; Salmon S; Malfroy B
Characterization of endopeptidase 3.4.24.11 ("enkephalinase") activity in human plasma and cerebrospinal fluid.
Biochemical pharmacology 1990;39(8):1353-6.
1990: Goedert M; Spillantini M G
Molecular neuropathology of Alzheimer's disease: in situ hybridization studies.
Cellular and molecular neurobiology 1990;10(1):159-74.
1990: Greenberg J M; Boehm T; Sofroniew M V; Keynes R J; Barton S C; Norris M L; Surani M A; Spillantini M G; Rabbits T H
Segmental and developmental regulation of a presumptive T-cell oncogene in the central nervous system.
Nature 1990;344(6262):158-60.
1989: Spillantini M G; Aloe L; Alleva E; De Simone R; Goedert M; Levi-Montalcini R
Nerve growth factor mRNA and protein increase in hypothalamus in a mouse model of aggression.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(21):8555-9.
1989: Allen S J; Dawbarn D; Spillantini M G; Goedert M; Wilcock G K; Moss T H; Semenenko F M
Distribution of beta-nerve growth factor receptors in the human basal forebrain.
The Journal of comparative neurology 1989;289(4):626-40.
1989: Spillantini M G; Hunt S P; Ulrich J; Goedert M
Expression and cellular localization of amyloid beta-protein precursor transcripts in normal human brain and in Alzheimer's disease.
Brain research. Molecular brain research 1989;6(2-3):143-50.
1989: Goedert M; Spillantini M G; Jakes R; Rutherford D; Crowther R A
Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease.
Neuron 1989;3(4):519-26.
1989: Geppetti P; Santicioli P; Rubini I; Spillantini M G; Maggi C A; Sicuteri F
Thiorphan increases capsaicin-evoked release of substance P from slices of dorsal spinal cord of guinea pig.
Neuroscience letters 1989;103(1):69-73.
1989: Goedert M; Spillantini M G; Potier M C; Ulrich J; Crowther R A
Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain.
The EMBO journal 1989;8(2):393-9.
1988: Maggi C A; Santicioli P; Geppetti P; Frilli S; Spillantini M G; Nediani C; Hunt S P; Meli A
Biochemical, anatomical and functional correlates of postnatal development of the capsaicin-sensitive innervation of the rat urinary bladder.
Brain research 1988;471(2):183-90.
1988: Amenta F; Spillantini M G; Cavallotti C; Geppetti P
Increase in substance P levels in the lung of old rats.
Archives of gerontology and geriatrics 1988;7(3):215-9.
1988: Baldi E; De Feo M L; Geppetti P; Carlà V; Maggi M; Pupilli C; Spillantini M G; Brocchi A; Mannelli M
Measurement of catecholamines, met-enkephalin, somatostatin and substance P-like immunoreactivities in 12 human pheochromocytomas.
Journal of endocrinological investigation 1988;11(2):133-8.
1987: Geppetti P; Maggi C A; Zecchi-Orlandini S; Santicioli P; Meli A; Frilli S; Spillantini M G; Amenta F
Substance P-like immunoreactivity in capsaicin-sensitive structures of the rat thymus.
Regulatory peptides 1987;18(5-6):321-9.
1987: Maggi C A; Geppetti P; Santicioli P; Spillantini M G; Frilli S; Meli A
The correlation between sensory-efferent functions mediated by the capsaicin-sensitive neurons and substance P content of the rat urinary bladder.
Neuroscience letters 1987;76(3):351-6.
1987: Geppetti P; Spillantini M G; Frilli S; Pietrini U; Fanciullacci M; Sicuteri F
Acute oral captopril inhibits angiotensin converting enzyme activity in human cerebrospinal fluid.
Journal of hypertension 1987;5(2):151-4.
1987: Geppetti P; Frilli S; Spillantini M G; Grieco A; Marchionni A; Damiani F; Sicuteri F
Evaluation of CSF neuropeptides and peptidase activities in primary headaches.
Cephalalgia : an international journal of headache 1987;7 Suppl 6():43-5.
1986: Spillantini M G; Panconesi A; Del Bianco P L; Sicuteri F
Enkephalinase and angiotensin converting enzyme activities in human venous and arterial plasma.
Neuropeptides 1986;8(2):111-7.
1986: Spillantini M G; Geppetti P; Fanciullacci M; Michelacci S; Lecomte J M; Sicuteri F
In vivo 'enkephalinase' inhibition by acetorphan in human plasma and CSF.
European journal of pharmacology 1986;125(1):147-50.
1986: Spillantini M G; Massotti M
Inhibition of penicillin-induced EEG discharges by low doses of morphine or naloxone in the rabbit. Evidence for a possible non-opioid receptor-mediated mechanism at the sensorimotor cortex.
Pharmacology, biochemistry, and behavior 1986;24(5):1241-6.
1986: Digiesi V; Baldi E; Scartabelli P; Masi F; Spillantini M G; Cerchiai G
[Plasma beta endorphin in man during partial immersion in water using the therapeutic method]
Minerva medica 1986;77(7-8):209-13.
1986: Baldi E; Spillantini M G; Cosenza-Biagioli E; Mainardi G; Cianciulli D; Carbone C; Panero C
Met-enkephalin-like immunoreactivity (MELI) and enkephalinase activity (EKA) in cord blood and newborns in the first hours of life.
Biological research in pregnancy and perinatology 1986;7(2):84-8.
1986: Baldi E; Conti P; Conti R; Fanciullacci M; Michelacci S; Salmon S; Sicuteri F; Spillantini M G
Hypernociceptive syndromes and pharmacological inhibition of endogenous opioid degradation.
International journal of clinical pharmacology research 1986;6(3):193-7.
1985: Sicuteri F; Fanciullacci M; Geppetti P; Renzi D; Caleri D; Spillantini M G
Substance P mechanism in cluster headache: evaluation in plasma and cerebrospinal fluid.
Cephalalgia : an international journal of headache 1985;5(3):143-9.
1982: Baldi E; Salmon S; Anselmi B; Spillantini M G; Cappelli G; Brocchi A; Sicuteri F
Intermittent hypoendorphinaemia in migraine attack.
Cephalalgia : an international journal of headache 1982;2(2):77-81.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Maria Grazia Spillantini

Research Profile (preview)

Chemicals & Drugs

Disorders

Anatomy

Procedures

Physiology

Living Beings

Concepts & Ideas

Phenomena

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Maria Grazia Spillantini (preview)

All Publications